February 28, 2015 11:33 AM ET


Company Overview of CellGenTech, Inc.

Company Overview

CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine/technology for the development of gene/cell therapies. The company provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; and arteriosclerotic disease, and cancer or degenerative neuropathies. CellGenTech, Inc. was founded in 2003 and is based in Chiba, Japan.

Chiba-dai Inohana Innovation Plaza #101

1-8-15, Inohana


Chiba,  260-0856


Founded in 2003


81 434 41 4121


81 434 41 4121

Key Executives for CellGenTech, Inc.

Founder, Chief Executive Officer and President
Senior Director of Business Development
Senior Director of Clinical Development
Senior Director of Pharmaceutical Affairs and Auditor
Senior Director of Clinical Development and Auditor
Compensation as of Fiscal Year 2014.

CellGenTech, Inc. Key Developments

CellGenTech, Inc. Presents at BioJapan 2013 World Business Forum, Oct-09-2013

CellGenTech, Inc. Presents at BioJapan 2013 World Business Forum, Oct-09-2013 . Venue: Pacifico Yokohama, Yokohama, Japan.

Similar Private Companies By Industry

Company Name Region
Bio Matrix Research, Inc. Asia
Kohjin Bio Co., Ltd. Asia
Kakuhiro Corporation Asia
GeneticLab Co., Ltd. Asia
Mebiopharm Co. Ltd. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CellGenTech, Inc., please visit www.cellgentech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.